•  

Start-Up Companies

Knitt Labs launches KnittBar, raises $50,000 on Kickstarter in six days

UTEST graduate company building a versatile, smart, modular power bar We've all been there: You reach over behind your TV to plug in yet another device to find your power bar’s out of available outlets. You wonder why your electricity bill’s so high and want to know which appliance is the culprit. You forget to turn something off (or did you?) and you’re already halfway to a meeting. Knitt Labs, Inc. has developed KnittBar to solve these frustrating problems for those who are ... Read more

Triphase announces positive results of phase 1 trial of Marizomib and Bevacizumab in malignant glioma

TORONTO and SAN DIEGO (June 4, 2016) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced positive results from its Phase 1 proof-of-concept study evaluating marizomib in combination with bevacizumab in patients with WHO grade IV malignant glioma. These results were presented in a poster session during the American Society for Clinical Oncology (ASCO) annual meeting in Chicago on June 4, 2016. “These results confirm our original hypothesis that this combination therapy is ... Read more

Dr. Raphael Hofstein in Biotechnology Focus: Canada’s Contagiously Creative Life Sciences Sector

Biotechnology Focus, a compendium of the Canadian life sciences industry, has published the following guest column by Dr. Raphael Hofstein, MaRS Innovation’s president & CEO, and Elizabeth Monier-Williams, director of marketing and communications. There’s a historical trend in Canadian culture with far-reaching effects for the way we do business, ranging from entertainment to academia to science. Namely, it’s that until quite recently, Canadians weren’t into cultivating national star systems. [1] As Gideon Hayden recently wrote for TechCrunch, if you’re a Canadian tall poppy ... Read more

Video: DashMD’s CEO and co-founder interviewed by Dx3 Canada

Amber Mac from Dx3 Canada interviewed Zack Fisch, CEO and co-founder of DashMD. In the video, Zack discusses DashMD's vision for a better healthcare system and what the company is doing in order to improve the discharge process for patients. About DashMD Dash MD seeks to improve the quality of healthcare by providing patients with the necessary tools, information, and resources that they need to successfully traverse their own personal and individualized road to recovery. Their Patient Engagement Platform will be downloadable to patients in ... Read more

The BBC features Flybits and Ryerson University’s Digital Media Zone

"With massive amounts of cash being pumped into development by Google, Facebook, Microsoft and context-aware startups such as Flybits, the PA in everybody’s pocket could soon be a reality," Nick Clayton wrote in BBC Capital about virtual personal assistants (Siri, Cortana, Alexa, etc.). Flybits was founded by Hossein Rahnama, Research and Innovation Director at Ryerson University Digital Media Zone in partnership with MaRS Innovation. Flybits is a software solution that makes it simple to personalize an app's behaviour. Digital marketers can use this information to then ... Read more

Formation Biologics Recognized As One of the Most Promising Life Science Companies by Rice Alliance

(May 31, 2016) – Formation Biologics was recognized as one of the Rice Alliance 10 Most Promising Life Science Companies at the 2016 Texas Life Science Forum hosted by the Rice Alliance for Technology and Entrepreneurship, BioHouston, and Texas Healthcare and BioScience Institute. The companies were chosen by industry experts and investors. The event is one of the largest life science venture capital conferences in the Southwest and featured more than 40 industry and investment speakers. Among more than 600 attendees were ... Read more

UTEST program announces investments in five U of T start-ups

Companies in fourth cohort developing products ranging from software to therapeutic platforms; applications for fifth cohort, in partnership with MLA48, open until May 27, 2016 TORONTO (May 9, 2016) — The University of Toronto Early-Stage Technology (UTEST) incubator, co-directed by U of T’s Innovations & Partnerships Office (IPO) and MaRS Innovation with financial support from the Connaught Fund, has announced five investments in start-up companies from Cohort 4. The five companies and the diverse sectors they target are: Ardra Bio, which is ... Read more

TrendMD graduates from Ycombinator and announces new partnerships

It’s been a busy quarter for UTEST company TrendMD. Fresh off their participation in Ycombinator’s Winter 2016 cohort, which was covered in TechCrunch, the company has announced partnerships with HighWire and Integra. TrendMD, a Canadian start-up company, is a content recommendation engine for scholarly publishers. They work with over 2,000 medical journals by organizing and tailoring information to the appropriate audiences. This functionality creates several opportunities for various researchers to promote their research and clinical practices in their respective fields. TrendMD launched through ... Read more

Triphase Accelerator Corporation expands collaboration with Celgene in developing Marizomib to treat gliomas

Company initiating two new clinical trials for recurrent and newly diagnosed malignant gliomas TORONTO and SAN DIEGO, (May 03, 2016) – Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced that it is expanding its current collaboration with Celgene Corp. in the development of marizomib for the potential treatment of malignant gliomas. The two companies will collaborate on a Phase 2 study using marizomib (MRZ) as monotherapy in recurrent glioblastoma, as well as a Phase ... Read more

Miroculus acquires Kapplex to advance diagnostics for complex diseases

Canadian innovation will give patients affordable, non-invasive, accurate test for cancer or infectious diseases; R&D team to remain in Toronto discovery district TORONTO and SAN FRANCISCO (May 3, 2016) — Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary Digital Microfluidic (DMF) platform is built upon the research of Dr. Aaron Wheeler, a world-leader in microfluidics research at the University of Toronto. This announcement was covered in GenomeWeb and PeHub. When ... Read more
Page 3 of 2412345...1020...Last »